blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP3962519

EP3962519 - CELLS EXPRESSING A CHIMERIC RECEPTOR FROM A MODIFIED CD247 LOCUS, RELATED POLYNUCLEOTIDES AND METHODS [Right-click to bookmark this link]
StatusRequest for examination was made
Status updated on  04.02.2022
Database last updated on 25.09.2024
FormerThe international publication has been made
Status updated on  06.11.2020
Formerunknown
Status updated on  29.05.2020
Most recent event   Tooltip13.03.2024New entry: Renewal fee paid 
Applicant(s)For all designated states
Juno Therapeutics, Inc.
400 Dexter Ave. N, Suite 1200
Seattle, WA 98109 / US
[2022/10]
Inventor(s)01 / BURLEIGH, Stephen Michael
c/o Juno Therapeutics, Inc. 400 Dexter Ave. N.
Suite 1200
Seattle, Washington 98109 / US
02 / NYE, Christopher Heath
c/o Juno Therapeutics, Inc. 400 Dexter Ave. N.
Suite 1200
Seattle, Washington 98109 / US
 [2022/10]
Representative(s)Carpmaels & Ransford LLP
One Southampton Row
London WC1B 5HA / GB
[2022/10]
Application number, filing date20727074.530.04.2020
[2022/10]
WO2020US30875
Priority number, dateUS201962841578P01.05.2019         Original published format: US 201962841578 P
[2022/10]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2020223571
Date:05.11.2020
Language:EN
[2020/45]
Type: A1 Application with search report 
No.:EP3962519
Date:09.03.2022
Language:EN
The application published by WIPO in one of the EPO official languages on 05.11.2020 takes the place of the publication of the European patent application.
[2022/10]
Search report(s)International search report - published on:EP05.11.2020
ClassificationIPC:A61K39/00, C07K14/725, C12N5/0783
[2022/10]
CPC:
C07K14/7051 (EP,IL,KR,US); C12N5/0636 (EP,IL,KR,US); A61K2239/46 (EP,IL,KR,US);
A61K2239/48 (EP,IL,KR,US); A61K39/4611 (EP,IL,KR,US); A61K39/4631 (EP,IL,KR,US);
A61K39/464417 (EP,IL,KR,US); A61K39/464429 (EP,IL,KR,US); A61P35/00 (KR,US);
C07K14/70521 (KR,US); C07K14/70578 (KR); C07K14/7151 (US);
C07K16/2878 (KR); C12N15/11 (US); C12N15/625 (US);
C12N15/86 (US); C12N15/907 (US); C12N9/22 (US);
A61K38/00 (US); C07K2317/622 (KR); C07K2319/02 (KR);
C07K2319/03 (EP,IL); C12N2310/20 (US); C12N2501/51 (KR);
C12N2501/515 (KR); C12N2501/599 (EP,IL); C12N2510/00 (EP,IL,KR);
C12N2750/14143 (KR,US); C12N2800/80 (US) (-)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2022/10]
Extension statesBA02.11.2021
ME02.11.2021
Validation statesKH02.11.2021
MA02.11.2021
MD02.11.2021
TN02.11.2021
TitleGerman:ZELLEN, DIE EINEN CHIMÄREN REZEPTOR AUS EINEM MODIFIZIERTEN CD247-LOCUS EXPRIMIEREN, VERWANDTE POLYNUKLEOTIDE UND VERFAHREN[2022/10]
English:CELLS EXPRESSING A CHIMERIC RECEPTOR FROM A MODIFIED CD247 LOCUS, RELATED POLYNUCLEOTIDES AND METHODS[2022/10]
French:CELLULES EXPRIMANT UN RÉCEPTEUR CHIMÉRIQUE À PARTIR D'UN LOCUS CD247 MODIFIÉ, POLYNUCLÉOTIDES ET PROCÉDÉS ASSOCIÉS[2022/10]
Entry into regional phase02.11.2021National basic fee paid 
02.11.2021Designation fee(s) paid 
02.11.2021Examination fee paid 
Examination procedure02.11.2021Examination requested  [2022/10]
02.11.2021Date on which the examining division has become responsible
22.06.2022Amendment by applicant (claims and/or description)
Fees paidRenewal fee
21.03.2022Renewal fee patent year 03
14.03.2023Renewal fee patent year 04
13.03.2024Renewal fee patent year 05
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited inInternational search[AD]WO2017093969  (NOVARTIS AG [CH], et al);
by applicantUS4452773
 US4690915
 US4795698
 US5033252
 US5052558
 US5087616
 WO9208796
 US5200084
 US5219740
 US5323907
 US5356802
 EP0452342
 WO9428143
 WO9519431
 US5436150
 US5487994
 WO9606166
 US5789538
 WO9853058
 WO9853059
 WO9853060
 WO9853057
 WO9854311
 US5925523
 US6007988
 US6013453
 WO0014257
 US6040177
 US6060273
 WO0027878
 US6140081
 US6200759
 US6207453
 WO0160970
 WO0188197
 WO0216536
 US6410319
 US6453242
 US6451995
 US2002131960
 US2002150914
 WO02099084
 US6503717
 WO03016496
 US6534261
 US6599692
 WO03068201
 US2003170238
 US2003223994
 US2003232410
 US6689558
 US2004191260
 US2005026157
 US2005064474
 US2005208489
 US2006034850
 US2006063231
 US7067317
 US7070995
 WO2006099875
 US2007092530
 US2007116690
 US7262054
 US7265209
 US7354762
 US2008159996
 US7446190
 US7446179
 US7446191
 WO2009072003
 WO2009080829
 US2009226474
 US2009304679
 US2010047805
 WO2010033140
 US2010218264
 US2010260748
 US2011003380
 US7888121
 US7914796
 US7951925
 US7972854
 US2011207221
 US8008450
 US2011265198
 US2011301073
 US2012017290
 US8110379
 US8153765
 WO2012092612
 US2012189622
 WO2012129514
 WO2012138927
 US8324353
 US8339645
 EP2537416
 US8389282
 US8398282
 US8409861
 US2013122591
 WO2013071154
 US2013137104
 US2013149337
 US8479118
 US2013177983
 US2013196373
 WO2013123061
 WO2013126726
 US2013287748
 WO2013166321
 US8586526
 US2013326645
 US8603477
 WO2014031687
 WO2014055668
 US8703489
 US2014120622
 US8802374
 WO2014127261
 US2014286987
 US2014294841
 US8911993
 WO2014210064
 US8945868
 US8956828
 US2015056705
 US9005973
 US9045763
 US2015266973
 WO2015142675
 US9150847
 WO2015161276
 US2015335708
 US9200266
 US9233125
 US2016024474
 US2016030477
 US9255250
 WO2016022994
 US2016046700
 WO2016030414
 US2016152723
 WO2016090327
 WO2016090320
 WO2016090329
 WO2016090312
 US2016272999
 US9458205
 US2017016027
 US2017051035
 WO2017093969
 US2017211075
 WO2017193107
 WO1991US08442
 WO1994US05601
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.